A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Several experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at residence.
After minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these communities, posts show black plastic packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially significant medical dangers”.
